Citadel Advisors’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$9.08M Buy
649,543
+560,996
+634% +$7.84M ﹤0.01% 1437
2025
Q1
$1.19M Sell
88,547
-269,811
-75% -$3.64M ﹤0.01% 3091
2024
Q4
$6.87M Buy
358,358
+117,091
+49% +$2.24M ﹤0.01% 1552
2024
Q3
$5.49M Buy
241,267
+196,596
+440% +$4.47M ﹤0.01% 1689
2024
Q2
$581K Sell
44,671
-717,740
-94% -$9.34M ﹤0.01% 3635
2024
Q1
$13.3M Sell
762,411
-124,230
-14% -$2.18M ﹤0.01% 1120
2023
Q4
$19.3M Buy
886,641
+784,210
+766% +$17.1M ﹤0.01% 880
2023
Q3
$1.57M Buy
102,431
+16,582
+19% +$254K ﹤0.01% 2606
2023
Q2
$2.04M Buy
85,849
+3,794
+5% +$90.3K ﹤0.01% 2412
2023
Q1
$2.09M Sell
82,055
-1,120,263
-93% -$28.5M ﹤0.01% 2507
2022
Q4
$35.1M Sell
1,202,318
-158,294
-12% -$4.62M 0.01% 601
2022
Q3
$27.9M Buy
1,360,612
+428,313
+46% +$8.78M 0.01% 646
2022
Q2
$10.8M Sell
932,299
-8,919
-0.9% -$103K ﹤0.01% 1220
2022
Q1
$17.4M Sell
941,218
-2,122
-0.2% -$39.2K ﹤0.01% 1006
2021
Q4
$18.7M Buy
+943,340
New +$18.7M ﹤0.01% 979
2021
Q2
Sell
-485,995
Closed -$44K 7160
2021
Q1
$44K Buy
485,995
+465,955
+2,325% +$42.2K ﹤0.01% 6122
2020
Q4
$330K Buy
20,040
+9,032
+82% +$149K ﹤0.01% 4162
2020
Q3
$128K Buy
11,008
+10,009
+1,002% +$116K ﹤0.01% 4200
2020
Q2
$17K Sell
999
-474
-32% -$8.07K ﹤0.01% 4504
2020
Q1
$10K Buy
+1,473
New +$10K ﹤0.01% 4741
2019
Q3
Sell
-1,851
Closed -$57K 5176
2019
Q2
$57K Buy
+1,851
New +$57K ﹤0.01% 4335
2019
Q1
Sell
-1,226
Closed -$55K 5068
2018
Q4
$55K Buy
1,226
+543
+80% +$24.4K ﹤0.01% 4096
2018
Q3
$57K Buy
+683
New +$57K ﹤0.01% 3993
2018
Q2
Sell
-1,112
Closed -$117K 4619
2018
Q1
$117K Buy
+1,112
New +$117K ﹤0.01% 3607
2016
Q4
Sell
-45
Closed -$5K 4142
2016
Q3
$5K Sell
45
-110
-71% -$12.2K ﹤0.01% 3511
2016
Q2
$15K Sell
155
-99
-39% -$9.58K ﹤0.01% 3267
2016
Q1
$29K Buy
254
+129
+103% +$14.7K ﹤0.01% 3090
2015
Q4
$21K Buy
+125
New +$21K ﹤0.01% 3612